BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback